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Introduction

Case Report

Neuroarthropathy, commonly referred to as Charcot joint,
results in fracture and progressive osseous destruction. The
foot and ankle are the most frequently involved.1 Patients in
the acute process, progress through a variety of stages until
consolidation or the reparative stage is reached.2,3 JeanMarie Charcot first described this condition in patients with
tertiary syphilis in 1868. It was later attributed to patients
with diabetes mellitus in 1936.1 Today, in the United States,
diabetes is the most common etiology of Charcot joint. This
destruction of the normal foot and ankle anatomy leads to
altered weight-bearing mechanics with decreased function
and skin ulceration. Treatment of Charcot joint is usually
non-operative with immobilization and limited weightbearing until the healing phase is reached.4 This may take
months, or even up to a year.5 It marks the beginning of
lifetime treatment and surveillance to prevent future
complications. These include ulceration, which often
leads to infection including osteomyelitis, and eventually
amputation.4
Though not fully understood, there have previously
been two proposed mechanisms behind neuroarthropathy.
Virchow and Volkman, postulated that changes leading to
an insensate foot allowed repetitive trauma which in turn
led to inflammatory and destructive phases. This accounts
for the minimal or absent history of trauma in some
diabetic patients who present with a Charcot joint.6 The
alternate theory proposed by the Frenchman Charcot stated
that autonomic disregulation led to altered vasoregulation
and vascular shunting followed by osteopenia and set
the stage for bony destruction with microtrauma.6 More
recent research has pointed to inflammatory cytokines
and molecular stimulation of osteoclast formation as being
involved.7
The following cases demonstrate severe destruction of the
ankle joint resulting in unbraceable deformity, instability,
and inability to ambulate. Realignment and fusion with
intramedullary nailing was performed in both cases.

Two patients with a Charcot ankle were evaluated for
consideration of alternative treatment to amputation.
The first patient is a 41-year-old female with diabetes and
end stage renal disease being considered for renal transplant.
She presented two years after sustaining a trauma to her left
foot and ankle. At the time of presentation she has a severe
deformity consisting of varus angulation of the ankle and
apex plantar deformity of the sole. (Figure 1) She was barely
able to ambulate in a cast boot with the deformity. Given
the lack of passive correction this was not a braceable
deformity. Though the skin was intact, the prominence of
the distal fibula with overlying callus was felt to be at high
risk of impending ulceration.
She underwent left ankle fusion with a hindfoot
intramedullary nail, and was kept non-weight-bearing for
two months. (Figure 2) This was followed by progression to
partial, then full weight-bearing in a cast boot. At six months
she was doing well with a healed fusion and improved
ambulation. A slight plantar prominence remained, which
was treated with custom plastizote insoles. At 8 months she
was pain free, walking in shoes, and had returned to work.
The second patient is a 36 year-old male with no initial
diagnosis of diabetes. He had a two year history of right
ankle instability symptoms with minimal pain. He had
no history of significant trauma, but did feel a “pop” while
rolling his ankle several years before. He was initially able
to ambulate in an air cast boot, though this became difficult
given his worsening varus instability and progressive
deformity. (Figure 3) He eventually had prominence of the
distal fibula with abrasions but no frank skin breakdown.
Due to concern for neuroarthropathy in this scenario, labs
were performed which revealed a glucose of 354 and HgA1c
of 12.1. The patient was referred for treatment of his newly
diagnosed diabetes.
After controlling his diabetes, he underwent right ankle
arthrodesis with a hindfoot nail. His post-operative course
was similar to our first patient, with good pain relief and a
functional foot at his 6 month follow-up. (Figure 4)
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Figure 1: Preoperative AP and lateral x-rays demonstrating varus
instability with weight-bearing, prominence of the fibula, and bone loss
from talus.

Figure 2: Postoperative AP and lateral x-rays with ankle realigned and
nail in position resulting in stable plantigrade foot at 6 months.

Discussion
The goal of treating Charcot neuroarthropathy is to obtain a
plantigrade foot which is stable and able to be put in a shoe.
This allows ambulation and improved functional use of the
limb. Additionally it corrects excessive deformity which
can lead to ulceration. Initially this is done with orthoses.
While many times these goals are achieved, this was not
attainable with these two patients. The bone destruction
progressively lead to instability, deformity and bony
prominence which prevented bracing and ambulation. By
virtue of the concomitant diabetes, these two individuals
were also predisposed to ulceration, infection, and
the eventual threat of amputation. Surgical correction
consisting of realigning and fusing the ankle is at times
an alternative to amputation when Charcot destruction is
severe. Such was the case for our two patients.
Candidates for this procedure should have sufficient
vascular supply and potential for healing and ambulation.
Though Charcot joint does not directly involve the blood
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Figure 3: Weight-bearing AP and lateral x-rays of the ankle
demonstrating prominent fibula from varus deformity and unstable
ankle.

Figure 4: Weight-bearing AP and lateral x-rays of the ankle 6 month
status post surgery demonstrating a stable well aligned foot

supply to the foot and ankle, there is a high prevalence
of peripheral artery disease in patients with diabetes. An
ischemic Charcot joint would necessitate revascularization
prior to surgical treatment.8 Candidates should also be free
of infection prior to surgical consideration and correction.
Many of the signs and symptoms of Charcot joint are
similar to infection, including swelling, erythema, elevated
temperature and inflammatory laboratory markers.
Additional studies may help differentiate osteomyelitis
from Charcot joint.9
Given the odds of complications inherent with these
procedures, patients must be compliant with the required
postoperative care to obtain the best chance possible for a
functional outcome. While these two patients have had a
good short term outcome, it is important to consider that
surgical complications are relatively high in this patient
population. Even with a successful surgery, constant
vigilance is required to prevent the underlying diabetes
complications of associated wounds, infection and
prolonged treatment.

Despite the high rate of complications in certain
situations, arthrodesis might allow for limb salvage. The
future may be more promising as salvage options for failed
arthrodesis using a blade plate have recently been reported
as well.10 Research into the pathophysiology may lead to new
targeted treatments for treatment and perhaps prevention.7

References
1. Van der Ven A, Chapman C, Bowker J. Charcot
neuroarthropathy of the foot and ankle. J Am Acad Ortho
Surg. 2009;17:562-571.
2. Eichenholtz SN. Charcot Joints. C.C. Thomas; 1966.
3. Shibata T, Tada K, Hashizume C. The results of arthrodesis
of the ankle for leprotic neuroarthropathy. J Bone Joint Surg.
1990;72A:749-756.
4. Caputo G, Ulbrecht J, Cavanagh P, Juliano P. The Charcot
foot in diabetes: six key points. Am Fam Physician. 1998 Jun
1;57(11):2705-2710.
5. Shen W, Wukich D. Orthopaedic surgery and the diabetic
Charcot foot. Med Clin N Am. 2013;97:873-882.
6. Chisolm K, Gilchrist J. The Charcot joint: A modern
neurologic perspective. J Clin Neuromusc Dis. 2011;13:1-13.
7. Jeffcoate W. Theories concerning the pathogenesis of the
acute Charcot foot suggest future therapy. Curr Diabetes
Rep. 2005;5:430-435.
8. Palena L, Brocco E, Manzi M. Critical limb ischemia
in association with Charcot neuroarthropathy: complex
endovascular therapy for limb salvage. Cardiovasc Intervent
Radiol. 2014;37:257-261.
9. Varma A. Charcot neuroarthropathy of the foot and
ankle: a review. J Foot Ankle Surg. 2013;52:740-749.
10. DiDomenico L, Brown D. Limb salvage: Revision of
failed intramedullary nail in hindfoot and ankle surgery
in the diabetic neuropathic patient. J Foot Ankle Surg.
2012;51:523-527.

Case Report

75

